Fixed dose combination therapy and CVD protection: "a need of the hour".
作者信息
Chopra H K
出版信息
Indian Heart J. 2009 Jul-Aug;61(4):316-21.
PMID:20635732
Abstract
摘要
相似文献
1
Fixed dose combination therapy and CVD protection: "a need of the hour".
Indian Heart J. 2009 Jul-Aug;61(4):316-21.
2
Polypill in cardiovascular disease: has it's time come?
Indian Heart J. 2009 Jul-Aug;61(4):322-7.
3
The Polypill in the prevention of cardiovascular disease.
Prev Med. 2011 Jan;52(1):16-7. doi: 10.1016/j.ypmed.2010.11.015. Epub 2010 Dec 2.
4
[The polypill: not an effective strategy for reduction of cardiovascular disease].
Ned Tijdschr Geneeskd. 2005 Jul 30;149(31):1741.
5
[The polypill: optimal strategy for reduction of cardiovascular disease].
Ned Tijdschr Geneeskd. 2005 Jul 30;149(31):1740.
6
Results of a Markov model analysis to assess the cost-effectiveness of a single tablet of fixed-dose amlodipine and atorvastatin for the primary prevention of cardiovascular disease in Korea.
Clin Ther. 2009 Oct;31(10):2189-203; discussion 2150-1. doi: 10.1016/j.clinthera.2009.10.015.
7
Benefits, challenges, and registerability of the polypill.
Eur Heart J. 2006 Jul;27(14):1651-6. doi: 10.1093/eurheartj/ehi841. Epub 2006 Apr 7.
8
Polypill: Can its Potential Enhancement of Efficacy Trigger New Interest?
Glob Heart. 2016 Dec;11(4):469-472. doi: 10.1016/j.gheart.2016.10.020.
9
Combination therapy to prevent cardiovascular disease: slow progress.
JAMA. 2013 Apr 17;309(15):1595-6. doi: 10.1001/jama.2013.3180.
10
A single pill for prevention?
Harv Heart Lett. 2009 Jul;19(11):6.
Zotero 插件